Understanding how BPH and prostate cancer are different
/Yet, for being two entirely different conditions, benign prostatic hyperplasia (BPH) and prostate cancer have a few similarities in common:
Read MoreYet, for being two entirely different conditions, benign prostatic hyperplasia (BPH) and prostate cancer have a few similarities in common:
Read MoreThe most common and deadly cancer for men in the U.S. (other than non-melanoma skin cancer) is prostate cancer.
Read MoreFor a small gland the size of a walnut, the prostate is responsible for keeping the male reproductive system on task. Located in front of the rectum and just below the bladder surrounding the urethra, over the course of a day, it has plenty of things to do keeping it busy.
Read MoreDr. David Samadi gives his expert opinion on how 3 out of 4 Americans are unaware that prostate cancer initially does not have noticeable symptoms.
Read MoreComparing the effectiveness of surgery versus radiation in the management of prostate cancer has been hotly debated for many years.
Read MoreProstate health is a primary focus all urologists want men to achieve. Yet prostate health is rarely on men’s health concerns radar.
Read MoreOne vital tool used to screen men for prostate cancer is PSA or prostate specific antigen testing.
Read MoreCall it an age thing. Benign prostatic hyperplasia (BPH) will be present in about one quarter of men by the time they reach the age of 55.
Read MoreA recent study of over 400,000 men under the age of 80 years found that prostate specific antigen (PSA) screening every 12 to 18 months decreased prostate cancer mortality and all-cause mortality risk by a significant 64% and 24% respectively, among men aged 55 to 74 years.
Read MoreFor men, receiving a diagnosis of prostate cancer can be anxiety-provoking and upsetting. For some of these men, hearing this information may be so distressing as to trigger thoughts of suicide.
Read MoreProstate cancer is not just an old man’s disease. Young men can get it too and Dr. David Samadi shines a light explaining why men younger than age 50 should get a PSA test as a baseline for comparison in the future.
Read MoreDr David Samadi comments on a study finding MRI fusion biopsy outperforming standard prostate biopsy in patients with a prior negative prostate biopsy.
Read More